How User Fees Influence Contraception in Low and Middle Income Countries

A Systematic Review

Dados Bibliográficos

ID14524566
AutoresCatherine Korachais (0000-0002-5869-563X, Catherine Korachais is Researcher in the Department of Public Health at the Institute of Tropical Medicine Antwerp Belgium), Elodie Macouillard (Elodie Macouillard is independent consultant), Bruno Meessen (0000-0002-0359-8621, Bruno Meessen is Professor of Health Economics in the Department of Public Health at the Institute of Tropical Medicine Nationalestraat 155, 2000 Antwerp Belgium)
Ano2016
Volume47
Fascículo4
Páginas341-356
Data de publicação2016-12-01
Peer ReviewedSim
Open AccessSim
TipoARTICLE
PeriódicoStudies in Family Planning (JOURNAL)
Identificadores do periódicoISSN: 0039-3665 • E-ISSN: 1728-4465
EditoraWiley (PUBLISHER • GB)
DOI10.1111/sifp.12005
IdiomaEN
Citações recebidas6
Referências citadas48

Accessible and quality reproductive health services are critical for low‐ and middle‐income countries (LMICs). After a decade of waning investment in family planning, interest and funding are growing once again. This article assesses whether introducing, removing, or changing user fees for contraception has an effect on contraceptive use. We conducted a search of 14 international databases. We included randomized controlled trials, interrupted‐time series analyses, controlled before‐and‐after study designs, and cohort studies that reported contraception‐related variables as an outcome and a change in the price of contraceptives as an intervention. Four studies were eligible but none was at low risk of bias overall. Most of these, as well as other studies not included in the present research, found that demand for contraception was not cost‐sensitive. We could draw no robust summary of evidence, strongly suggesting that further research in this area is needed